Risk factors for emphysema cigarette smoking is associated with a reduction in the association rate constant of lung α1-antitrypsin for neutrophil elastase

Journal of Clinical Investigation

Volumn 87, Issue 3, 1991, Pages 1060-1065

  Ogushi, F ^a   Hubbard, R C ^a   Vogelmeier, C ^a   Fells, G A ^a   Crystal, R G ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Antiprotease; Enzyme; Oxidation; Protease

Indexed keywords

ALPHA 1 ANTITRYPSIN; ELASTASE;

ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; EMPHYSEMA; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY SYSTEM;

ALPHA 1-ANTITRYPSIN; EMPHYSEMA; HUMAN; KINETICS; LUNG; NEUTROPHILS; PANCREATIC ELASTASE; PLANTS, TOXIC; PROTEIN BINDING; RISK FACTORS; SMOKING; TOBACCO;

EID: 0025897211     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI115066     Document Type: Article

References (63)

1. Snider, G. L., J. Kleinerman, W. M. Thurlbeck, and Z. H. Bengali. 1985. The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases Workshop. Am. Rev. Respir. Dis. 132:182-185.
2. Thurlbeck, W. M., J. A. Henderson, R. G. Fraser, and D. V. Bates. 1970. Chronic obstructive lung disease. A comparison between clinical, roentgenologic. functional and morphologic criteria in chronic bronchitis, emphysema, asthma and bronchiectasis. Medicine (Baltimore). 49:81-145.
3. Hugh-Jones, P., and W. Whimster. 1978. The etiology and management of disabling emphysema. Am. Rev. Respir. Dis. 117:343-377.
4. Smoking and Health; Report of the Advisory Committee to the Surgeon General of the Public Health Service. U.S. Dept of Health, Education, and Welfare. 1984. Washington, D.C. p. 14-57.
5. Auerbach, O., E. C. Hammond, L. Garfinkel, and C. Benante. 1972. Relation of smoking and age to emphysema. Whole-lung section study. N. Engl. J. Med. 286:853-857.
6. Janoff, A. 1985. Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. Am. Rev. Respir. Dis. 132:417-433.
7. Gadek, J. E., G. A. Fells, R. L. Zimmerman, S. I. Rennard, and R. G. Crystal. 1981. Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. J. Clin. Invest. 68:889-898.
8. Stone, P. J. 1983. The elastase-antielastase hypothesis of the pathogenesis of emphysema. Clin. Chest Med. 4:405-412.
9. Laurell, C. B., and S. Eriksson. 1963. The electrophoretic α1-globulin pattern of serum in α1-antitrypsin deficiency. Scand. J. Clin. Lab. Invest. 15:132-140.
10. Gross, P., E. A. Pfitzer, E. Tolker, M. A. Babyak, and M. Kaschak. 1965. Experimental emphysema: its production with papain in normal and silicotic rats. Arch. Environ. Health. 11:50-58.
11. Gadek, J. E., and R. G. Crystal. 1982. α1-antitrypsin deficiency. In The Metabolic Basis of Inherited Disease. J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson, J. L. Goldstein, and M. S. Brown, editors. McGraw-Hill Inc., New York. 1450-1467.
12. Carrell, R. W., J.-O. Jeppsson, C.-B. Laurell, S. O. Brennan, M. C. Owen. L. Vaughan, and D. R. Boswell. 1982. Structure and variation of human α1-antitrypsin. Nature (Lond.). 298:329-334.
13. Janoff, A., R. White, H. Carp, S. Harel, R. Dearing, and D. Lee. 1979. Lung injury induced by leukocytic proteases. Am. J. Pathol. 97:111-129.
14. Bieth, J. G. 1986. Elastases: catalytic and biological properties. In Regulation of Matrix Accumulation. R. Mechan, editor. Academic Press, New York, 217-320.
15. Travis, J., and G. Salvesen. 1983. Human plasma proteinase inhibitors. Annu. Rev. Biochem. 52:655-709.
16. Perlmutter, D. H., F. S. Cole, P. Kilbridge, T. H. Rossing, and H. R. Colten. 1985. Expression of the α1-proteinase inhibitor gene in human monocytes and macrophages. Proc. Natl. Acad. Sci. USA. 82:795-799.
17. Mornex, J.-F., A. Chytil-Weir, Y. Martinet, M. Courtney, J.-P. LeCocq, and R. G. Crystal. 1986. Expression of the alpha 1-antitrypsin gene in mononuclear phagocytes of normal and alpha 1-antitrypsin deficient individuals. J. Clin. Invest. 77:1952-1961.
18. Kueppers, F., and L. F. Black. 1974. α1-antitrypsin and its deficiency. Am. Rev. Respir. Dis. 110:176-194.
19. Morse, J. O. 1978. Alpha 1-antitrypsin deficiency. N. Engl. J. Med. 299:1045-1048 and 1099-1105.
20. Hunninghake, G. W., and R. G. Crystal. 1983. Cigarette smoking and lung destruction: accumulation of neutrophils in the lungs of cigarette smokers. Am. Rev. Respir. Dis. 128:833-838.
21. Ludwig, P. W., B. A. Schwartz, J. R. Hoidal, and D. E. Niewoehner. 1985. Cigarette smoking causes accumulation of polymorphonuclear leukocytes in alveolar septum. Am. Rev. Respir. Dis 131:828-830.
22. Olsen, G. N., J. O. Harris, J. R. Castle, R. H. Waldman, and H. J. Karmgard, 1975. Alpha-1-antitrypsin content in the serum, alveolar macrophages, and alveolar lavage fluid of smoking and nonsmoking normal subjects. J. Clin. Invest. 55:427-430.
23. Gadek, J. E., G. A. Fells, and R. G. Crystal. 1979. Cigarette smoking induces functional antiprotease deficiency in the lower respiratory tract of humans. Science (Wash. DC). 206:1315-1316.
24. Janoff, A., and H. Carp. 1977. Possible mechanisms of emphysema in smokers: cigarette smoke condensate suppresses protease inhibition in vitro. Am. Rev. Respir. Dis. 116:65-72.
25. Janoff, A., H. Carp, and D. K. Lee. 1979. Cigarette smoke inhalation decreases a 1-antitrypsin activity in rat lung. Science (Wash. DC). 206:1313-1314.
26. Johnson, D., and J. Travis. 1979. The oxidative inactivation of human α-1-proteinase inhibitor: further evidence for methionine at the active center. J Biol. Chem. 254:4022-4026.
27. Pryor, W. A., M. M. Dooley, and D. F. Church. 1986. The mechanisms of the inactivation of human alpha-1-proteinase inhibitor by gas-phase cigarette smoke. Adv. Free Radical Biol. in Med. 2:161-188.
28. Carp, H., and A. Janoff. 1980. Potential mediator of inflammation. Phagocyte-derived oxidants suppress the elastase-inhibitory capacity of alpha 1-proteinase inhibitor in vitro. J. Clin. Invest. 66:987-995.
29. Cohen, A. B., and H. L. James. 1982. Reduction of the elastase inhibitory capacity of alpha 1-antitrypsin by peroxides in cigarette smoke: an analysis of brands and filters. Am. Rev. Respir. Dis. 126:25-30.
30. 358 α1-antitrypsin. Am. Rev. Respir. Dis. 133:A218.
31. Carp, H., F. Miller, J. R. Hoidal, and A. Janoff. 1982. Potential mechanism of emphysema: α1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity. Proc. Natl. Acad. Sci. USA. 79:2041-2045.
32. Abboud, R. T., T. Fera, A. Richter, M. Z. Tabona, and S. Johal. 1985. Acute effect of smoking on the functional activity of alpha 1-protease inhibitor in bronchoalveolar lavage fluid. Am. Rev. Respir. Dis. 131:79-85.
33. El-Yamani, J., A. Hayem, J. J. Lafitte, B. Gressier, and J. Mizon. 1986. Functional and immunoreactive α1-proteinase inhibitor in bronchoalveolar lavages: methodological studies. Bull Eur. Physiopathol. Respir. 22:359-363.
34. Stone, P. J., J. D. Calore, S. E. McGowan, J. Bernardo, G. L. Snider, and C. Franzblau. 1983. Functional α1-protease inhibitor in the lower respiratory tract of cigarette smokers is not decreased. Science (Wash. DC). 221:1187-1189.
35. Boudier, C., A. Pelletier, G. Pauli, and J. G. Bieth, 1983. The functional activity of α1-proteinase inhibitor in bronchoalveolar lavage fluids from healthy human smokers and non-smokers. Clin. Chim. Acta. 132:309-315.
36. Jochum, M., A. Pelletier, C. Boudier, G. Pauli, and J. G. Bieth. 1985. The concentration of leukocyte elastase-α-proteinase inhibitor complex in bronchoalveolar lavage fluids from healthy human subjects. Am. Rev. Respir. Dis. 132:913-914.
37. Wewers, M. D., D. J. Herzyk, and J. E. Gadek. 1989. Comparison of smoker and nonsmoker lavage fluid for the rate of association with neutrophil elastase. Am. J. Respir. Cell. Mol. Biol. 1:423-429.
38. Cox, W., A. M. Johnson, and M. K. Fagerhol. 1980. Report of nomenclature meeting for α1-antitrypsin. Hum. Genet. 53:429-433.
39. Saltini, C., A. J. Hance, V. J. Ferrans, F. Basset, P. B. Bitterman, and R. G. Crystal. 1984. Accurate quantification of cells recovered by bronchoalveolar lavage. Am. Rev. Respir. Dis. 130:650-658.
40. Rennard, S. I., G. Basset, D. Lecossier, K. M. O'Donnell, P. Pinkston, P. G. Martin, and R. G. Crystal. 1986. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 60:532-538.
41. Rennard, S. I., R. Berg, G. R. Martin, J. M. Foidart, and P. G. Robey, 1980. Enzyme-linked immunoassay (ELISA) for connective tissue components. Anal. Biochem. 104:205-214.
42. Pannell, R., D. Johnson, and J. Travis. 1974. Isolation and properties of human plasma α-1-proteinase inhibitor. Biochemistry. 13:5439-5445.
43. Jeppsson, J.-O., C.-B. Laurell, and M. Fagerhol. 1978. Properties of isolated human α1-antitrypsins of Pi types M. S and Z. Eur. J. Biochem. 83:143-153.
44. Straus, S. D., G. A. Fells, M. D. Wewers, M. Courtney, L.-H. Tessier, P. Tolstoshev, J.-P. LeCocq, and R. G. Crystal. 1985. Evaluation of recombinant DNA-directed E. coli produced α1-antitrypsin as an anti-neutrophil elastase for potential use as replacement therapy of α-antitrypsin deficiency. Biochem. Biophys. Res. Commun. 130:1177-1184.
45. Laurell, C.-B., J. Pierce, U. Persson, and E. Thulin. 1975. Purification of α1-antitrypsin from plasma through thiol-disulfide interchange. Eur. J. Biochem. 57:107-113.
46. Sugiura, M., S. Hayakawa, T. Adachi, Y. Ito, K. Hirano, and S. Sawaki, 1981. A simple one-step purification of human α1-proteinase inhibitor by immunoadsorbent column chromatography. J. Biochem. Biophys. Meth. 5:243-249.
47. Beatty, K., J. Bieth, and J. Travis. Kinetics of association of serine proteinases with native and oxidized α-1-proteinase inhibitor and α-1-antichymotrypsin. 1980. J. Biol. Chem. 255:3931-3934.
48. Bieth, J. G. 1984. In vivo significance of kinetic constants of protein proteinase inhibitors. Biochem. Med. 32:387-397.
49. Bieth, J. G. 1980. Pathophysiological interpretation of kinetic constants of protease inhibitors. Bull. Eur. Physiopathol. Respir. 16(Suppl.):183-195.
50. Hance, A. J., and R. G. Crystal. 1975. The connective tissue of lung. Am. Rev. Respir. Dis. 112:657-711.
51. Karlinsky, J. B., and G. L. Snider. 1978. Animal models of emphysema. Am. Rev. Respir. Dis. 117:1109-1133.
52. Damiano, V. V., A. Tsang, U. Kucich, W. R. Abrams, J. Rosenbloom, P. Kimbel, M. Fallahnejad, and G. Weinbaum. 1986. Immunolocalization of clastase in human emphysematous lungs. J. Clin. Invest. 78:482-493.
53. Janoff, A., L. Raju, and R. Dearing. 1983. Levels of elastase activity in bronchoalveolar lavage fluids of healthy smokers and nonsmokers. Am. Rev. Respir. Dis. 127:540-544.
54. Morse, J. D., M. D. Lebowitz. M. D. Knudson, and B. Burrows. 1975. A community study of the relationship of alpha 1-antitrypsin levels to obstructive lung diseases. N. Engl. J. Med. 292:278-281.
55. Bruce, R. M., B. H. Cohen, E. L. Diamond, R. J. Fallat, R. J. Knudson. M. D. Lebowitz, C. Mittman, C. D. Patterson, and M. S. Tockman. 1984. Collaborative study to assess risk of lung disease in PiMZ phenotype subjects. Am. Rev. Respir. Dis. 130:386-390.
56. Hoidal, J. R., R. B. Fox, P. A. LeMarbe, R. Perri, and J. E. Repine. 1975. Altered oxidative metabolic responses in vitro of alveolar macrophages from asymptomatic cigarette smokers. Am. Rev. Respir. Dis. 123:85-89.
57. Richter, A. M., R. T. Abboud, S. S. Johal, and T. A. Fera. 1986. Acute effect of smoking on Superoxide production by pulmonary alveolar macrophages. Lung. 164:233-242.
58. Carp, H., and A. Janoff. 1979. In vitro suppression of serum elastase-inhibitory capacity by reactive oxygen species generated by phagocytosing polymorphonuclear leukocytes. J. Clin. Invest. 63:793-797.
59. Janoff, A., C. George-Nascimento, and S. Rosenberg. 1986. A genetically engineered, mutant human alpha-1-proteinase inhibitor is more resistant than the normal inhibitor to oxidative inactivation by chemicals, enzymes, cells, and cigarette smoke. Am. Rev. Respir. Dis. 133:353-356.
60. Zaslow, M. C., R. A. Clark, P. J. Stone, J. D. Calore, G. L. Snider, and C. Franzblau. 1983. Human neutrophil elastase does not bind to alpha 1-protease inhibitor that has been exposed to activated human neutrophils. Am. Rev. Respir. Dis. 128:434-439.
61. Clark, R. A., P. J. Stone, A. El Hag, J. D. Calore, and C. Franzblau. 1981. Myeloperoxidase-catalyzed inactivation of α1-protease inhibitor by human neutrophils. J. Biol. Chem. 256:3348-3353.
62. Niewoehner, D. D., J. Kleinerman, and D. B. Rice. 1974. Pathologic changes in the peripheral airways of young cigarette smokers. N. Engl. J. Med. 291:755-758.
63. Beatty, K., N. Matheson, and J. Travis. 1984. Kinetic and chemical evidence for the inability of oxidized α1-proteinase inhibitor to protect lung elastin from elastolytic degradation. Hoppe-Seyler's Z. Physiol. Chem. 365:5731-736.